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Abstract
Background: The rapid and accurate detection and identification of the new subtype of the
pathogens is crucial for diagnosis, treatment and control of the contagious disease outbreak. Here,
in this study, an approach to detect and identify Escherichia coli O157:H7 and Vibrio cholerae O139
was established using oligonucleotide microarray. We coupled multiplex PCR with oligonucleotide
microarray to construct an assay suitable for simultaneous identification of two subtypes of the
pathogens.
Results: The stx1, stx2 gene and uidA gene having the specific mutant spot were chosen as the
targets for Escherichia coli O157:H7, and meanwhile the ctxA, tcpA, and LPSgt gene for Vibrio cholerae
O139. The oligonucleotide microarray was composed of eight probes including negative control
and positive control from 16S rDNA gene. The six primers were designed to amplify target
fragments in two triplex PCR, and then hybridized with oligonucleotide microarray. An internal
control would be to run a PCR reaction in parallel. Multiplex PCR did not produce any non-specific
amplicons when 149 related species or genera of standard bacteria were tested (100% specificity).
In addition, Escherichia coli O157:H7 and Escherichia coli O157:non-H7, Vibrio cholerae O139 and
Vibrio cholerae O1 had been discriminated respectively. Using recombinant plasmid and target
pathogens, we were able to detect positive hybridization signals with 102 copies/µL and 103 cfu/mL
per reaction.
Conclusion: The DNA microarray assay reported here could detect and identify Escherichia coli
O157:H7 and Vibrio cholerae O139, and furthermore the subtype was distinguished. This assay was
a specific and sensitive tool for simultaneous detection and identification of the new subtype of two
pathogens causing diarrhea in human.
Background
Escherichia coli O157:H7 and Vibrio cholerae O139 are
lethal pathogens capable of causing severe infectious dis-
eases, characterized by acute outbreak, and large scale
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ple Public of China shown [1], many incidents related to
diarrhea due to two pathogens happened in recent year.
The control and prevention means were extremely effec-
tive, since two kinds of new serotypes appeared. Mean-
while the government had taken many measures for
studying detection and therapy assay. Therefore, we devel-
oped an assay for detecting the new serotypes of two path-
ogens. E. coli O157:H7 is capable of causing severe clinical
symptoms such as enterohemorrhage and hemolytic ure-
mic syndrome [2,3]. It can outbreak epidemically through
the contamination of foods and water [4]. The patho-
genicity of E. coli O157:H7 is related to various specific
genes such as Shiga genes stx1, stx2 [5,6] and β-glucuroni-
dase gene uidA (gusA) [7,8]. In some studies, stx genes
were used to identify E. coli O157:H7 [9], but these genes
existed in some O157: non-H7 serotypes, as well as some
other types of pathogenic E. coli [10]. Therefore, mere
detection of stx genes is not reliable for the purpose of
identifying E. coli O157 serotype, and detection of specific
genes to E. coli O157:H7 must be involved. The previous
study also indicated that a strictly specific base mutation
T93G occurs in the uidA gene of E. coli O157:H7 [6,11]. As
a result, nucleic acid hybridization was used to detect this
conserved mutation spot T93G of uidA gene in order to
discriminate O157:H7 from other stx-producing intestinal
bacteria.
Vibrio cholerae O139 is a strain of bacterium discovered in
1992 [12]. It can result in severe infectious diseases
mainly accompanying with symptoms of diarrhea, char-
acterized by acute outbreak, rapid spread, broad affected
area, and large scale prevalence [13]. It was indicated that
Vibrio cholerae O139 derived from Vibrio cholerae serotype
O1 [14,15]. Both Vibrio cholerae O139 and Vibrio cholerae
O1 have two principal virulence genes, ctxA and tcpA [16],
yet they are different in the gene composition and
sequence of LPSgt [17].
For a long time being, the traditional diagnosis of patho-
genic E. coli O157:H7 and Vibrio cholerae O139 is mainly
based on the conventional bacterial culture, which is a
laborious and time-consuming procedure. It will take sev-
eral days to obtain precise diagnostic results [18]. There-
fore, it was very important to establish a rapid and specific
method for detection and identification of pathogenic
bacteria. Oligonucleotide microarray technology has been
developed and widely used in the modern biology and life
science research in recent years. It is featured by high
throughput, low cost, and parallel detection of multiple
genes simultaneously [9,19,20].
In the present study, a low-density oligonucleotide micro-
array was developed. Combined with multiplex PCR, vir-
ulence genes (ctxA, tcpA, stx1, stx2) and serotype specific
genes (LPSgt for Vibrio cholerae O139 and uidA for E. coli
O157:H7) are detected using the oligonucleotide microar-
ray to detect and identify the pathogenic strains of Vibrio
cholerae O139 and E. coli O157:H7 from clinical speci-
mens simultaneously.
Results
Optimization of triplex PCR
The triplex PCR was used to amplify the target gene seg-
ments in E. coli O157:H7 and Vibrio cholerae O139. In
multiplex asymmetric PCR reaction, the variation of the
ratio of forward primer to reverse primer and concentra-
tions impacted the amplification efficiency obviously.
Therefore, the signal intensities of hybridization were
highly related to the ratio and amount of forward primer
to reverse fluorescent primer for each gene. After the opti-
mization, three PCR products in one tube had good spe-
cificity and average amplification efficiency. The
concentration of primers was showed in Table 1, and then
the result of agarose gel electrophoresis was shown in Fig-
ure 1.
Table 1: Triplex PCR primers for amplifying the target genes in E. coli O157:H7 and Vibrio cholerae O139
Target gene Target organism Sequence(5'-3') PCR product length (bp) Concentration in PCR mixture
Stx1 E. coli O157 F: GAA TTT ACC TTA GAC TTC TCG AC 250 0.15 µmol/L
R: TCC TGT TAA CAA ATC CTG TCA C 0.75 µmol/L
Stx2 E. coli O157 F: TAC GAT AGA CTT TTC GAC TCA AC 207 0.1 µmol/L
R: TCA ATA ATC AGA CGA AGA TGG TC 0.5 µmol/L
UidA E. coli O157:H7 F: TAA TGA GGA GTC CCT TAT GTT AC 179 0.1 µmol/L
R: ACT GAT CGT TAA AAC TGC CTG G 0.5 µmol/L
CtxA Vibrio cholerae F: ACT CAG ACG GGA TTT GTT AGG C 304 0.15 µmol/L
R: ATC TAT CTC TGT AGC CCC TAT TAC 0.75 µmol/L
TcpA Vibrio cholerae F: TTG ACC CAA GCA CAA TGT AAG AC 241 0.15 µmol/L
R: CTA CTG TGA ATG GAG CAG TTC C 0.75 µmol/L
LPSgt Vibrio cholerae F: ACA TCT GTA GGG ATT GTA TTG AC 340 0.2 µmol/L
O139 R: ATA ACA ACT GAG ATA TCA AGC GTC 1.0 µmol/LPage 2 of 10
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The 60 candidate probes were spotted in an array format
of 6 rows × 10 columns. The PCR products labeled by flu-
orescence were mixed with hybridization solution and
then hybridized with the probe array. The suitable probe
for each gene was selected according to the specificity and
hybridization signal intensity, which was analyzed by
using GenePix 4.0 software program. The screening result
of candidate probes was shown in Figure 2, and then the
hybridization signal intensity corresponding to each can-
didate probe was shown in Figure 3. The statistical analy-
sis of the quantified signal intensities indicated: stx1 No.7
probe, stx2 No.10 probe, uidA No.9 probe, and LPSgt No.
10 probe, had stronger signal intensity than that of other
probes, at any same level of the PCR template amount,
and in the meantime there are no non-specific signals.
No.9 probe of uidA was a shorter probe (19 bp) contain-
ing +93 mutant spot in the middle of the sequence. With
comparison to the No. 10 probe (without mutant point),
this probe was strictly specific to the single base mutant
uidA gene of E. coli O157:H7, indicating its applicability
in detection of the uidA gene mutation spot. No.3, No.4,
and No.6 probes for ctxA had statistically proximal signal
intensities. Nevertheless, No.4 probe was more specific
than the others. No.2, No.5, and No.9 probes for tcpA also
had statistically proximal signal intensities at higher level
of DNA template amount; whereas, No.9 probe had
apparently higher signal intensities than No.2, No.5
probes at lower level of DNA template amount.
As a result, the optimal detecting probes for the six target
genes of two pathogens were selected as follows: stx1 No.7
probe, stx2 No.10 probe, uidA No.9 probe, ctxA No.4
probe, tcpA No.9 probe, LPSgt No.10 probe.
In addition, the bacterial universal probe was used as a
positive control probes for verifying the PCR reaction was
not inhibited by extraction impurities. And a plant gene
segment with little sequence homology to the intestinal
bacteria was chosen as a negative control probe. The final
array format was shown as Figure 4. And the sequences of
the optimal probe were listed in Table 2.
Specificity
The 149 strains of intestinal bacteria including various
serotypes (parts as shown in Table 3) were detected under
the optimal condition of triplex PCR and hybridization
for testing the specificity of this oligonucleotide microar-
ray. Two sets of triplex PCRs were performed to amplify
bacterial DNA templates. Cy3 labeled PCR products were
mixed and hybridized with the probe array fixed on the
glass slides.
It was shown that, 8 strains of E. coli O157:H7 had posi-
tive signal on stx1, stx2, and uidA probes. Two strains of E.
coli O157: non-H7 had positive signals on stx1 and stx2
probes. Additionally, 3 strains of E. coli O157: non H7
Figure 3
Figure 2
Figure 1Page 3 of 10
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probe; 2 strains of E. coli O157: non H7 had signal on stx1
and stx2 probe, and furthermore E. coli O157: non-H7
had no signal on uidA probe. The results indicated that all
the detected E. coli O157:H7 had both stx1 and stx2 toxin
genes, whereas E. coli O157: non-H7 and other intestinal
bacteria had one or both of the stx1 and stx2 toxin genes.
However, the uidA probe can be used for identification of
the O157:H7 from other intestinal bacteria accurately.
Seventy four strains of Vibrio cholerae O139 had positive
signals on ctxA, tcpA, LPSgt probes; Vibrio cholerae (Ogawa
and 569B) had positive signals on ctxA, tcpA probes. The
results showed that ctxA, tcpA toxin genes may be detected
in Vibrio cholerae O1 or O139 subtype. However, the
probe specific to the unique region of LPSgt gene of Vibrio
cholerae O139 was a strictly discriminating probe for
Vibrio cholerae O139.
The fifty five strains of other intestinal bacteria and three
non O1 non O139 Vibrio cholerae produces no detectable
signal on the oligonucleotide microarray. The above
results were shown in Table 4. Meanwhile, the hybridiza-
tion images were shown in Figure 5, from which we could
observe that the positive signals emerged orderly at the
position corresponding to two pathogens from pure bac-
terial cultures; at the same time the signals of high inten-
sity appeared at the position of positive control probes,
and furthermore, no signals emerged at the position of
negative control probes and blank probes.
Sensitivity
We chose 149 standard strains of intestinal bacteria
including various serotypes for determining the cutoff
value of each probe. A large number of results from
hybridization with positive strains, negative strains and
blank control indicated that the signal intensity of nega-
tive strains and blank control was greatly lower than that
of positive strains. Thereby, cutoff value of the probe was
the average signal intensity from negative bacteria and
blank control plus 2SD. Based on the cutoff value corre-
sponding to each probe (Table 5), the sensitivity of this
DNA microarray assay was evaluated.
The recombinant plasmids were quantified and prepared
in 10-fold serial dilutions, which were used as the PCR
templates to test the sensitivity of the oligonucleotide
microarray. In the triplex PCR mixture, when the template
plasmids were 103copies/µL, the PCR products can be
detected both by using agarose gel electrophoresis and
from the positive signal confirmed according to the cutoff
value when hybridized with the detecting probe array;
when the template plasmids were 102copies/µL, the PCR
products, which can be detected only by hybridizing with
the detecting probe array (the ratio of signal to noise was
greater than 4), produce no visible bands on the same aga-
rose gel electrophoresis. Furthermore, when the template
plasmids were 10 copies/µL, PCR products can not be
detected either by using agarose gel electrophoresis or by
hybridization with the detecting probe array. The above
results and the value of signal intensity corresponding to
serial dilution were shown in Figure 6 and in Figure 7
respectively. Furthermore, the test limit of real time PCR
was 102 copies/µL(data not shown). Similarly when serial
dilution (10-fold) of two targets from 106~101cfu/mL
were evaluated, the positive signals were observed with a
detection limit of 103cfu/mL. The result of statistical anal-
ysis was shown in Figure 8. Meanwhile, the test limit of
real time PCR and conventional microbiological methods
Table 2: Oligonucleotide probe sequences for identification of E. coli O157:H7 and Vibrio cholerae O139
Target gene Sequence(5'-3') Length (bp) Tm(°C)a
Stx1 GTA CGT CTT TAC TGA TGA TTG ATA GTG GCA CAG GG 35 73.5
Stx2 AGT TAT TTT GCT GTG GAT ATA CGA GGG CTT GAT GT 35 69.6
uidA TGG AAT TGA GCA GCG TTG G 19 70.1
ctxA CAT ACA GTC CTC ATC CAG ATG AAC AAG AAG TTT CTG CTT TAG GTG 45 75.0
tcpA CAG GAA GTG CCA ACT TAA ACC TAA CTA ATA TCA CGC ATG TTG AGA 45 76.8
LPSgt TCG ATA AGA AGA GAT AAA GAT CTG AGT TAT CTA AAG ATA TTT G 43 71.2
Negative control TCT TCG CCA GAG GCC TGC TAG CCT GGT TCA AGA TAC TAC C 40 68.5
Labeling control Complimentary sequence of the reverse primer 20 70.5
aTm(°C) was calculated using primer premier 5.0
Figure 4Page 4 of 10
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shown).
Detection of clinical specimens and double-blind mock 
samples
The clinical specimens were anus swabs collected from 60
patients in an epidemic Vibrio cholerae in Zhejiang Prov-
ince, China. A total of 342 clinical specimens were
detected by conventional microbiological methods, oligo-
nucleotide microarray and fluorescent real-time PCR. The
detection results were shown in Table 6.
It was shown that 89, 137, and 142 specimens were iden-
tified as Vibrio cholerae O139 with the methods of conven-
Table 3: part of the standard strains
Species ATCC accession noa
Escherichia coli O157:H7 44752, 43889, 43859, W933, 882364, EDL 933
Escherichia coli O157:non-H7 S14–91, CB569, 5412, 493/89
Escherichia coli O55:H7 5905, 5A, 5B
Escherichia coli O26:H11 13C07, 13C08
Escherichia coli O111:NM 403, 405, TW00186
Vibrio cholerae 16025, 16026, 16028,
Vibrio cholerae O139 M045, 1837
Vibrio cholerae O1 569B, Ogawa
Vibrio parahaemolyticus 20502, 20506, 20507, 20511
Enterobacter aerogenes CMCC (B) 45103,
Proteus spp 49027, 49101, 49102, 49103
Yersinia enterocolitica 52207, 52211, 52215, 52217, 52302
Salmonella spp 50001, 50004, 50013
Clostridium botulinum 64201, 64203
Brucella spp 23456, 11778
Campylobacter jejuni 33560, 7709, 29428, 43429
Staphylococcus aureus 26001, 26111, 26113,13565,27661
Aeromonas hydrophila 10501, 35654, 23211, 23213
Citrobacter freundii CMCC (B) 48016
Clostridium perfringens 64711,13048
Listeria monocytogenes 54003, 54005, 54006, 54007
Shigella spp 51081, 3596, 451424
Bacillus cereus 63301,6051,63509
Enterococcus faecalis 32219, 32220, 32221, 32223
Species ATCC accession noa
Escherichia coli O157:H7 44752, 43889, 43859, W933, 882364, EDL 933
Escherichia coli O157:non-H7 S14–91, CB569, 5412, 493/89
Escherichia coli O55:H7 5905, 5A, 5B
Escherichia coli O26:H11 13C07, 13C08
Escherichia coli O111:NM 403, 405, TW00186
Vibrio cholerae 16025, 16026, 16028,
Vibrio cholerae O139 M045, 1837
Vibrio cholerae O1 569B, Ogawa
Vibrio parahaemolyticus 20502, 20506, 20507, 20511
Enterobacter aerogenes CMCC (B) 45103,
Proteus spp 49027, 49101, 49102, 49103
Yersinia enterocolitica 52207, 52211, 52215, 52217, 52302
Salmonella spp 50001, 50004, 50013
Clostridium botulinum 64201, 64203
Brucella spp 23456, 11778
Campylobacter jejuni 33560, 7709, 29428, 43429
Staphylococcus aureus 26001, 26111, 26113,13565,27661
Aeromonas hydrophila 10501, 35654, 23211, 23213
Citrobacter freundii CMCC (B) 48016
Clostridium perfringens 64711,13048
Listeria monocytogenes 54003, 54005, 54006, 54007
Shigella spp 51081, 3596, 451424
Bacillus cereus 63301,6051,63509
Enterococcus faecalis 32219, 32220, 32221, 32223Page 5 of 10
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real-time PCR respectively. These results clearly indicated
that the accuracy of oligonucleotide microarray was suita-
ble for detection and identification of clinical specimen.
Furthermore, through statistical analysis the p values (p <
0.05) were calculated in order to show that differences in
the oligonucleotide microarray assay and conventional
microbiological method were indeed significant in Table
6. The reason was that there were the target inactive organ-
isms in the collected specimens in order that Vibrio chol-
erae O139 was detected positively using conventional
culture.
Because most of clinical specimens collected were
infected, we could not guarantee the validity of detecting
E. coli O157:H7 in samples. Then, the 10 double-blind
mock samples were prepared. From the results (Table 7)
we observed that 8 of 10 mock samples were identified E.
coli O157:H7 positive, and furthermore the above results
were the same to double-blind results.
Discussion
Oligonucleotide microarray, based on multiplex PCR
reaction, could simultaneously detect multiple target
genes of a pathogen, and therefore identify pathogens
accurately. An oligonucleotide microarray containing six
probes was established in the present study, capable of
identifying Enterohemorrhagic Escherichia coli O157:H7
and Vibrio cholerae O139 at the same time. The reliability
of oligonucleotide microarray to identify a specific sero-
type of bacterium from other types of bacteria with the
highly homologous origin was closely depended on the
specificity of probe to the "genetic marker" in the discrim-
inating gene. In this study, uidA and LPSgt were selected as
the discriminating genes, and the T+93G spot mutation in
uidA gene specific to E. coli O157:H7 and the unique
region in LPSgt gene specific to Vibrio cholerae O139 were
selected as the genetic markers. After screening the candi-
date probes with bacteria with negative or positive pres-
ence of the target genes, 6 probes were selected with the
best specificity and sensitivity.
It is crucial for a suitable detection assay to avoid false
negative and false positive results efficiently. Then in this
article, we chosen 16S rDNA gene as an internal control
referred to previous study in order to confirm the genomic
DNA was present and the process of PCR was not affected
by the inhibitors and then a segment with little sequence
homology to the intestinal bacteria was chosen as a nega-
tive control probe. When two duplex PCR reactions car-
ried out, we ran a parallel reaction for amplifying a
universal 500 bp fragment from 16S rDNA gene. The
hybridization images showed that the signals of high
intensity appeared at the position of positive control
probes for every PCR and hybridization except negative
control reaction and no any signals appeared at the posi-
tion of negative control probes and blank probes. Accord-
ingly, the results illustrated that the detection results
Figure 5
Table 4: Test results of the 149 strains of intestinal bacteria using oligonucleotide microarray
Strains Number stx1 stx2 uidA ctxA tcpA LPSgt
E. coli O157:H7 8(5.3%) + + + - - -
E. coli O157: non H7 2(1.3%) + + - - - -
E. coli O157: nonH7 3(2.0%) + - - - - -
EIEC 2(2.0%) + - - - - -
Vibrio cholerae O139 74(49.7%) - - - + + +
Vibrio cholerae O1 2(1.3%) - - - + + -
Vibrio cholerae Non O1 non O139 3(2.0%) - - - - - -
Other pathogens 55(36.9%) - - - - - -
a American Type Culture Collection (ATCC) accession numberPage 6 of 10
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and accurate.
The value of cutoff was used to evaluating the result
obtained from DNA microarray. In this paper, we had
determined the cutoff value of each probe by trial and
error. As the above results shown, based on the cutoff
value corresponding to each probe, this oligonucleotide
microarray could detect 102 copies of plasmid DNA tem-
plates in the triplex PCR reaction and 103 cfu/mL of target
pathogens. For specimen with lower amount of bacteria
than the detection limit, such as E. coli O157:H7 having
minimal infective dose as low as 10 cells of bacteria, the
step of bacterial cultivation and enrichment prior to PCR
amplification was prerequisite for the purpose of avoiding
the false-negative results. The detection accuracy of the
oligonucleotide microarray established in this study was
obviously higher than that of the conventional microbio-
logical method and at a proximal level as that of the real-
time PCR assay. However, compared with real time PCR,
the oligonucleotide microarray can detect the major toxin
genes that contribute to the severity of the infectious dis-
eases as well as the unique gene regions specific to the E.
coli O157:H7 uidA and Vibrio cholera O139 LPSgt. Mean-
while, the above results also showed that the sensitivity of
this assay was lower than that of the conventional micro-
biological method. However the culture method cost
more time and operation steps, and furthermore the sen-
sitivity of DNA microarray, 103 cfu/mL, was sufficient to
detect clinical specimen.
As we known, the oligonucleotide microarray was more
sensitive than that of PCR assay. The main reason was that
the result of PCR was identified using agarose gel electro-
phoresis, which limited the sensitivity of PCR. However,
the results of detection of clinical specimens indicated
that the sensitivity of oligonucleotide microarray was sim-
ilar to that of real-time PCR. This result was reasonable
because the principle of real time PCR contained PCR and
hybridization with specific probe.
As it is very difficult to choose PCR fragments with differ-
ent size for target pathogens and optimize and establish a
stable and reproducible multiplex PCR and real-time PCR,
the oligonucleotide microarray based on multiplex PCR
could produce more diagnostic information than the real-
time PCR. It can detect multiple pathogens and multiple
target genes simultaneously in one assay.
In conclusion, a rapid and reliable DNA microarray assay
was developed for detecting and identifying E. coli
O157:H7 and Vibrio cholera O139 simultaneously. The
specific probes fixed on the slide were chose from the stx1,
stx2, and uidA genes for E. coli O157:H7 and the ctxA, tcpA,
Figure 6
Table 5: Cutoff value of the probe
Target gene Species Average of negative bacteria and blank 
control signal intensity
SD Cutoff valuea
ctxA Vibrio cholerae O139 1783.12 64.27 1847.39
TcpA 1739.338 68.253 1807.591
LPSgt 1637.29 57.175 1694.465
stx1 Escherichia coli 1691.284 71.22 1762.504
Stx2 O157:H7 1790.385 78.473 1868.858
UidA 1802.1746 69.181 1871.3556
16S rDNA internal control 1598.5629 24.75 1623.3129
a cutoff value = average of negative bacteria and blank control signal intensity + 2 SDPage 7 of 10
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more, this DNA microarray could distinguish from E. coli
O157:H7 and E. coli O157: non-H7, Vibrio cholera O139
and Vibrio cholera non-O139. Then, the above results
obviously indicated that the assay described here was
applied to epidemiological study, clinical diagnosis, sur-
veillance of food and public health, control of infectious
diseases. Meanwhile, this study was a commence fabricat-
ing a DNA microarray for detecting and identifying many
genera or species of pathogens, and we are adding more
genera or species of bacteria including food borne patho-
gen and acute human pathogenic microorganisms to this
detection system in order to increase the range, accuracy
and discriminatory power of simultaneous detection.
Methods
Bacterial strains and genomic DNA isolation from the anus 
swabs
The standard strains of E. coli O157:H7 and Vibrio cholerae
O139 were provided by the National Institute for the
Control of Pharmaceutical and Biological Products of
China. The local standard strains of Vibrio cholerae O1
(569B), Vibrio cholerae Ogawa, Vibrio cholerae O139 and E.
coli O157:H7 and the standard strains of some common
intestinal bacteria and the clinical specimens were pro-
vided by the Center for Disease Prevention and Control of
Zhejiang province, China. Part of the standard strains was
listed in Table 3. The pathogens that isolated from clinical
specimens were identified by the conventional microbio-
logical methods [21,22]. The double-blind 10 mock sam-
ples infected by E. coli O157:H7 were prepared. The
genomic DNA from clinical samples was extracted by cen-
trifugation as previously described [23]. Meanwhile DNA
of the standard strains was extracted with UNIQ-10 col-
umn Genomic DNA Minipreps Kit (Sangon Co., LTD
Shanghai, China), according to the manufacturer's instruc-
tions. Purified genomic DNAs were stored at -20°C in TE.
Primers and probes
Based on references and published gene sequences in
GenBank, stx1, stx2 and uidA genes were selected for E. coli
O157:H7, ctxA, tcpA, LPSgt genes for Vibrio cholerae O139.
Various sequences of each gene were collected and aligned
by software Vector NTI Suite 9/AlignX. Primers and
probes were designed using software Primer 5.0. The spe-
cificity of sequences was analyzed by BLAST GenBank. The
10 candidate probes were designed for each gene (totally
60 candidate probes), 19–60 mer in length. The Tm values
of six primers and according to probes were approxi-
mately identical, and then the length of each PCR product
was less than 500 bp. 16S rDNA gene was chosen as an
internal control for verifying that genomic DNA templates
of pathogens were present and the PCR reaction carried
out successfully. Based on the previous study, a 500-bp
fragment was obtained through PCR amplification using
16S-F1 (CGCTGGCGGCAGGCCTAACACATGC) and
16S-R1 (CGCGGCTGCTGGCACGGAGTTAGCC), and
then the bacterial universal probe (ACTGAGACACGGTC
CAGACTCCTACGGGAGGCAGCAGTAGGGAATATTG)
was chosen as a marker for checking validity of internal
control [24]. The oligonucleotide probes were modified
with amino residue at 3' end. The reverse primer was
labeled with fluorescent dye Cy3 at 5' end. The sequences
of primers and probes were shown in Table 1 and Table 2
respectively.
PCR amplification
A volume of 20 µL conventional PCR mixture contains:
0.1 µmol/L the forward primer, 1.0 µmol/L the reverse
primer, 100 µmol/L dNTPs, 50–100 ng DNA template, 1×
PCR buffer and 1.5 U Taq polymerase (Promega). PCR
products were amplified in a thermal cycler (PTC-100™
programmable thermal controller, MJ. research Inc)
under the following condition: initial denaturation(5 min
at 94°C) followed by 40 cycles of denaturation (30 sec at
94°C), annealing(30 sec 62°C) and extension(30 sec at
72°C). A final extension step was carried out for 5 min at
Figure 8
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optimal final concentration of primers in triplex PCR reac-
tion was determined. The PCR condition and concentra-
tion of each component for 16S rDNA gene referred to the
previous study [24].
Construction of recombinant plasmid as standard 
template
DNA templates were extracted from standard strains of E.
coli O157:H7 W933 and Vibrio cholerae O139 M045
respectively, which were amplified using conventional
PCR with unlabelled primers. The PCR products were
purified, and then inserted into pGEM-T vectors
(Promega). Consecutively, the recombinant products
were transformed into Escherichia coli DH5α (Promega),
and incubated overnight at 37°C with shaking. Recom-
binant plasmids were screened using the T7 and SP6 prim-
ers and extracted using Promega Plasmid Extracting Kit,
which procedure was according to the manual. After puri-
fication, the insert DNA fragments were identified
through sequencing using automatic DNA sequencer
(CEQ-2000). The number of plasmid copies was counted
as previously described [25]. The plasmid was 10-fold
serial diluted and stored at -20°C for use as PCR template.
Preparation of the oligonucleotide microarray
The 3' end amino-modified probes were diluted to a final
concentration of 50 µmol/L in spotting solutions (3 × SSC
and 0.01% SDS) and were transferred into 384-well
micro-titer plates in volumes of 10 µL. The probe solu-
tions were spotted to aldehyde-coated glass slides (CEL
Associates) with a microarray printer (Cartisan), which
deposits 0.5 nL at each spotting site, resulting in spots of
200 µM in diameter. The humidity during spotting was
90% and the temperature kept at 23°C. After spotting,
slides were incubated for another 2 h under the same con-
ditions and stored at room temperature for at least 24 h
before use.
Hybridization and signal detection
The Cy3-labeled PCR products were mixed with the
hybridization solution (6 × SSC, 1 × Denhard, 0.2% SDS),
and 10 µL of the hybridization solution was transferred to
the hybridization area on the glass slide. The slide was
incubated in 42°C water bath for 1 h in a tightly-sealed
hybridization chamber. After incubation, the slide was
washed sequentially in washing solution A (1 × SSC, 0.2%
SDS), washing solution B (0.2 × SSC) and washing solu-
tion C (0.1 × SSC) for 1 min each.
The glass slides were scanned using the GenePix 4000B
(Axon), with excitation at 540 nm and emission at 570
nm (Cy3). Sixteen-bit TIFF images of 10 micrometers res-
olution were analyzed with software GenePix Pro 4.0. The
signal intensity is displayed according to spot color,
whose order from high to low is white, red, yellow, green,
and blue. After the removal of local background, the aver-
age signal intensity of each probe was calculated. The cut-
off value was evaluated in order to confirm whether the
target was considered to be positive or not.
Assay sensitivity
The sensitivity was evaluated according to serial dilution
(10-fold) from 104~101 copies/µL. Meanwhile, according
to Jin et al[24], the sensitivity about the amount of bacte-
ria in clinical specimen was determined. Each dilution
series of genomic DNA were mixed with a natural back-
ground of genomic DNA from stool samples of healthy
volunteers. The genomic DNA of stool samples was
extracted as shown above. After the whole operation, two
kinds of sensitivity were determined through signal inten-
sity according to cutoff value. Additionally, the sensitivity
of real time PCR (In real time PCR, the fluorescent probe
detected the same unique region in LPSgt gene as the
detecting probe of the oligonucleotide microarray) (DaAn
Gene Co., Ltd, Guangzhou, China) and conventional
Table 7: E. coli O157:H7 testing result of the 10 double-blind 
mock samples
Sample No. Oligonucleotide microarray test Double-blind result
1 Negative Negative
2 E. coli O157:H7 E. coli O157:H7
3 E. coli O157:H7 E. coli O157:H7
4 E. coli O157:H7 E. coli O157:H7
5 E. coli O157:H7 E. coli O157:H7
6 Negative Negative
7 E. coli O157:H7 E. coli O157:H7
8 E. coli O157:H7 E. coli O157:H7
9 E. coli O157:H7 E. coli O157:H7
10 E. coli O157:H7 E. coli O157:H7
Table 6: Vibrio cholera O139 testing result of the clinical specimens
Method Target Positive Rate (%)
Conventional microbiological method Vibrio cholera O139 89 26.0*
Oligonucleotide microarray ctxA, tcpA, LPSgt 137 40.0
Fluorescent real time PCR LPSgt 142 41.5
*: p < 0.05Page 9 of 10
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compare the sensitivity of this assay with other methods.
Statistical analysis
Statistical analysis in this paper was made with SPSS for
Windows software (version 11.5, Chicago, Il, USA).
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